Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
---|
01/31/2001 | EP1071790A1 Phytic acid biosynthetic enzymes |
01/31/2001 | EP1071789A1 Phytic acid biosynthetic enzymes |
01/31/2001 | EP1071788A1 Novel nucleic acids and polypeptides related to a farnesyl-directed cysteine carboxymethyltransferase |
01/31/2001 | EP1071787A1 Tao protein kinases and methods of use |
01/31/2001 | EP1071786A2 Genetically engineered yeast and mutants thereof for the efficient fermentation of lignocellulose hydrolysates |
01/31/2001 | EP1071785A2 Interconversion of plant fatty acid desaturases and hydroxylases |
01/31/2001 | EP1071782A2 Seed-coat promoters, genes and gene products |
01/31/2001 | EP1071769A1 Secretion of glycosylated proteins using a tissue plasminogen activator pro-sequence |
01/31/2001 | EP1071762A1 Control of gene expression |
01/31/2001 | EP1071760A1 Genetically modified lactic acid bacteria having modified diacetyl reductase activities |
01/31/2001 | EP1071759A1 Assay methods for modulators of hematopoietic cell phosphatase |
01/31/2001 | EP1071756A1 PURIFICATION OF HUMAN ACID $g(a)-GLUCOSIDASE |
01/31/2001 | EP1071755A1 Human bile salt-stimulated lipase (bssl) obtainable from transgenic sheep |
01/31/2001 | EP1071754A1 Recombinant secoisolariciresinol dehydrogenase, and methods of use |
01/31/2001 | EP1071753A2 Nucleic acid molecules with novel chemical compositions capable of modulating gene expression |
01/31/2001 | EP1071746A2 Process for preparing doxorubicin |
01/31/2001 | EP1071706A1 Rapidly degrading gfp-fusion proteins and methods of use |
01/31/2001 | EP1071700A1 Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity |
01/31/2001 | EP1071697A1 Regulated target expression for screening |
01/31/2001 | EP1071696A1 Programmed cell death and caspase-12 |
01/31/2001 | EP1071471A2 Methods and vector constructs for making transgenic non-human animals which ubiquitously express a heterologous gene |
01/31/2001 | EP1071334A1 A method for efficient and highly selective control of microorganisms |
01/31/2001 | EP0920528A4 Synthetic protein folding catalysis |
01/31/2001 | EP0706569B1 Sbp members with a chemical moiety covalently bound within the binding site; production and selection thereof |
01/31/2001 | EP0592583B1 Method for the inhibition of aldh-i useful in the treatment of alcohol dependence or alcohol abuse |
01/31/2001 | CN1282389A Continuous biopolishing of cellulose-containing fabrics |
01/31/2001 | CN1282373A Method for producing amylase enzymes |
01/31/2001 | CN1282370A Matrix granule |
01/31/2001 | CN1282369A Polypeptides having aminopepyidase activity and nucleic acids encoding same |
01/31/2001 | CN1282367A Granule with hydrated barrier material |
01/30/2001 | US6180850 Ku70 is the noncatalytic subunit of dna-protein kinase, encoded by specified polynucleotides; transgenic plants; modulating the level of ku70 in a plant; modulating nucleic acid expression in plants |
01/30/2001 | US6180766 Nucleosides and oligonucleotides containing boron clusters |
01/30/2001 | US6180619 Prenyl transferase inhibitors |
01/30/2001 | US6180613 AAV-mediated delivery of DNA to cells of the nervous system |
01/30/2001 | US6180612 Methods and compositions for targeting DNA metabolic processes using aminoglycoside derivatives |
01/30/2001 | US6180602 Derived from mrnas expressed in human cells |
01/30/2001 | US6180406 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
01/30/2001 | US6180399 Synthetic rna having endonuclease activity and altered substrate binding site; for multifunctional enzyme |
01/30/2001 | US6180390 Pseudonocardia; for the fermentation of hydrolase polypeptide |
01/30/2001 | US6180388 Process for the enzymatic hydrolysis of polyamide 6.6 to give adipic acid monomers and hexamethylenediamine monomers |
01/30/2001 | US6180387 Nucleotide sequence coding an enzymatic polypeptide; for the detection of bactericides and batericidal agonist and antagonists which prevent bacterial infection |
01/30/2001 | US6180386 DNA sequences coding for the human proteins Tx and Ty related to the interleukin-1beta converting enzyme |
01/30/2001 | US6180385 Nucleotide sequences coding a viral enzymatic polypeptide; for the detection of modulators of proteolytic activity |
01/30/2001 | US6180384 Compounds |
01/30/2001 | US6180383 Insect proteolytic enzyme; for the prevention of insect infestation |
01/30/2001 | US6180382 Xylanase derived from a bacillus species, expression vectors for such xylanase and other proteins, host organisms therefor and use thereof |
01/30/2001 | US6180381 Pseudomonas chlororaphis microorganism, polyurethane degrading enzyme obtained therefrom, and method of use |
01/30/2001 | US6180380 Cloning of a new member of the serine threonine kinase family |
01/30/2001 | US6180379 Eukaryotic transport protein; for utilization in the ubiquination and degradation of cell cycle polypeptides |
01/30/2001 | US6180378 Immobilization of bioactive protein in phyllosilicates |
01/30/2001 | US6180367 Recovering heterologous proteins from microorganisms; culture transformed microorganismal cells with expression vector, incubate with inducer, propagate, lyse cells and recover accumulated heterologous protein |
01/30/2001 | US6180366 Methods for producing heterologous polypeptides in trichothecene-deficient |
01/30/2001 | US6180363 Recoding of DNA sequences permitting expression in yeast and obtained transformed yeast |
01/30/2001 | US6180361 Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporin C synthetase and deacetylcephalosporin C synthetase |
01/30/2001 | US6180360 Process of producing β-lactam antibiotics applying micro-organisms with increased ligase activity |
01/30/2001 | US6180359 Industrial scale process for the preparation of 2-hydroxy-4-methylbutyric acid using a nitrilase |
01/30/2001 | US6180358 Detecting modulators of kinase activity; incubate modulator with cells expressing kinase polypeptide, detect modulation of kinase activity |
01/30/2001 | US6180343 Green fluorescent protein fusions with random peptides |
01/30/2001 | US6180342 Vacuolar proton ATPase subunits |
01/30/2001 | US6180336 Labelling and selection of molecules |
01/30/2001 | US6180334 Artificial recombinant substrate (rAGG 1) and native aggrecan to determine the proteolytic activity of ‘aggrecanase’ in cell culture systems |
01/30/2001 | CA2238098C Use of nadph oxidase inhibitors for the manufacture of a medicament for prevention of atherosclerosis |
01/30/2001 | CA2139931C Purification of factor ix |
01/27/2001 | CA2314569A1 Methods for treating skin pigmentation |
01/25/2001 | WO2001006015A1 NOVEL GLYCOSYL SULFOTRANSFERASES GST-4α, GST-4β, AND GST-6 |
01/25/2001 | WO2001005996A1 Process for producing optically active pyridineethanol derivatives |
01/25/2001 | WO2001005984A2 Flavonoid biosynthesis |
01/25/2001 | WO2001005983A1 Dsp-11 dual-specificity map kinase phosphatase |
01/25/2001 | WO2001005982A1 Method for the production of l-amino acids from their racemic n-acetyl-d, l-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes |
01/25/2001 | WO2001005980A1 Compositions and methods for fumonisin detoxification |
01/25/2001 | WO2001005979A1 Process for producing target substance by fermentation method |
01/25/2001 | WO2001005975A1 MAIZE ORTHOLOGUES OF BACTERIAL RuvB:cDNAS AND USES THEREOF |
01/25/2001 | WO2001005961A1 Recombinase-based methods for producing expression vectors and compositions for use in practicing the same |
01/25/2001 | WO2001005956A2 Sialyation of n-linked glycoproteins in the baculovirus expression vector system |
01/25/2001 | WO2001005954A1 Antisense modulation of liver glycogen phosphorylase expression |
01/25/2001 | WO2001005952A2 Plant genes |
01/25/2001 | WO2001005949A1 Membrane separation process for purifying, concentrating and densifying enzyme solutions with polyols |
01/25/2001 | WO2001005948A1 Assay of the activation state of platelets |
01/25/2001 | WO2001005837A1 Method for assaying compounds affecting smooth muscle contractile state |
01/25/2001 | WO2001005826A2 Chimeric polypeptides of serum albumin and uses related thereto |
01/25/2001 | WO2001005823A2 Tryptase inhibitor |
01/25/2001 | WO2001005811A2 Cyclic peptidomimetic urokinase receptor antagonists |
01/25/2001 | WO2001005772A1 Pyrazinones, compositions containing such compounds |
01/25/2001 | WO2001005419A2 Agent for treating cardiac diseases |
01/25/2001 | WO2001005405A1 Folylpolyglutamyl synthetase gene transfer to enhance antifolate drug sensitivity |
01/25/2001 | WO2001005353A2 USE OF FVIIa OR A TISSUE FACTOR ANTAGONIST FOR REGULATING GENE EXPRESSION AND CELL MIGRATION OR CHEMOTAXIS |
01/25/2001 | WO2000068399A3 Vector-mediated delivery of integrating transposon sequences |
01/25/2001 | WO2000068240A8 NOVEL aroA |
01/25/2001 | WO2000061787A3 gyrA |
01/25/2001 | WO2000061763A3 Proteins related to gaba metabolism |
01/25/2001 | WO2000058486A3 Maize ku80 homolog and uses thereof |
01/25/2001 | WO2000057837A3 Compositions and methods for effecting the levels of cholesterol |
01/25/2001 | WO2000050616A3 Sequences for improving the efficiency of secretion of non-secreted proteins from mammalian and insect cells |
01/25/2001 | WO2000049139A3 A caspase activated protein kinase |
01/25/2001 | WO2000047728A3 Soybean glutathione-s-transferase enzymes |
01/25/2001 | WO2000042196A3 Human methionine synthase reductase: cloning, and methods for evaluating risk of neural tube defects, cardiovascular disease, cancer, and down's syndrome |
01/25/2001 | DE19934408A1 New fungal orotic acid phosphoribosyltransferase gene, useful as a selection marker in recombinant protein expression systems |
01/25/2001 | DE19933701A1 Zyklische peptidomimetische Urokinaserezeptorantagonisten Cyclic peptidomimetic Urokinaserezeptorantagonisten |
01/25/2001 | CA2379983A1 Dsp-11 dual-specificity map kinase phosphatase |
01/25/2001 | CA2379849A1 Process for the preparation of l-amino acids from their racemic n-acetyl-d,l derivatives by enzymatic resolution by means of isolated, recombinant enzymes |